{"id":354,"date":"2019-11-03T17:23:44","date_gmt":"2019-11-03T15:23:44","guid":{"rendered":"http:\/\/cratia.com\/?post_type=countries&#038;p=354"},"modified":"2023-04-27T14:49:30","modified_gmt":"2023-04-27T11:49:30","slug":"registration-of-medicines","status":"publish","type":"countries","link":"https:\/\/cratia.com\/en\/countries\/belarus\/registration-of-medicines\/","title":{"rendered":"Registration of medicines"},"content":{"rendered":"<p><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">According to the Law of the Republic of Belarus \u201cOn medicinal products\u201d, import and sale of medicines in Belarus are allowed only after state registration (confirmation of state registration). Both finished medicinal products and active pharmaceutical ingredients are subject to registration.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Registration Certificate is issued in the name of the Applicant (Marketing Authorization Holder &#8211; MAH) that can be both a resident and a non-resident of the Republic of Belarus.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Expert evaluation during registration of finished medicinal products and active pharmaceutical ingredients is performed by the Unitary Enterprise \u201cCenter for Expert Evaluation and Testing in Health Care\u201d of the Ministry of Health of the Republic of Belarus (website: <\/span><a href=\"http:\/\/www.rceth.by\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">http:\/\/www.rceth.by\/<\/span><\/a><span style=\"font-weight: 400;\">).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Registration of medicinal products may be performed under the \u201cnational\u201d procedure until 31 December 2020, or under the \u201ccentralized\u201d procedure; and only under the &#8220;centralized&#8221; procedure of the EAEU after 31 December 2020.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The procedure for national registration is described below. You can get information about<a href=\"\/en\/countries\/evrazijskij-ekonomicheskij-soyuz\/registracziya-lekarstvennyh-sredstv\/\"> registration under the EAEU\u2019s unified rules by clicking on the link<\/a>.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The national registration procedure in Belarus follows a &#8220;general&#8221; or &#8220;simplified&#8221; route. Registration under the \u201csimplified\u201d route is available for medicines registered in countries with high regulatory standards.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Simplified state registration<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Starting from 31 December 2019, Presidential Decree No. 499 &#8220;On Circulation of Medicines&#8221; approved medicines that are subject to state registration in a simplified procedure:<\/span><\/p>\n<ol style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Medicinal products registered by authorized bodies of foreign states: Australian Union, Austrian Republic, United States of America, Canada, Swiss Confederation, Japan, United Kingdom of Great Britain and Northern Ireland, Federal Republic of Germany, Kingdom of Denmark, Kingdom of the Netherlands, Kingdom of Sweden, Kingdom of Spain, Portuguese Republic.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Medicines registered by the competent authority of the European Union under the central procedure for application in the territory of States: Australian Union, Canada, Republic of Austria, United States of America, Japan, Swiss Confederation, United Kingdom of Great Britain and Northern Ireland, Federal Republic of Germany, Kingdom of Denmark, Kingdom of the Netherlands, Kingdom of Spain, Portugal, Kingdom of Sweden.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Medicines for tuberculosis, hepatitis C, HIV, vaccines that have undergone a World Health Organization prequalification programme in accordance with the WHO\/PQT and HPV Joint Procedure of 16 May 2018 to assess and accelerate government registration of pharmaceuticals and vaccines prequalified by WHO.<\/span><\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Procedure of specialized assessment of registration materials under \u201csimplified\u201d procedure should not exceed 30 working days. State fees for the &#8220;simplified&#8221; registration procedure are also decreased.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>National registration by \u201cgeneral\u201d route\u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The procedure for national state registration of medicinal products was approved by Law No. 161-3 \u201cOn medicinal products\u201d and Resolution No. 156 \u201cOn approving the consolidated list of administrative procedures\u201d with amendments dated July 28, 2018.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Belarus is a country with high standards of regulation of marketed medicinal products. Inconsistencies between approved and actual packaging layouts, instructions for use and (or) package leaflets, quality certificates may cause rejection of the medicinal product and temporary or permanent prohibition on sales.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The registration dossier is accepted both in the national and in the CTD format. Regardless of the format of the registration dossier, it is necessary to develop specific national documents, namely:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Application for registration of the medicinal product.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">ND (Normative document) &#8211; regulatory document that includes the composition of the finished product, specification for release and shelf life, quality control methods, information on storage conditions, information on the manufacturers, etc.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Instructions for medical use for the prescription medicinal product and (or) package leaflet for the OTC medicinal product.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Graphical layouts of the primary and secondary packaging.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The last update of Regulation No. 52 introduced special requirements to validation documents, specifications and Normative document (ND), confirmation of copies of provided reports on drug stability, documents of the substance manufacturer and many others were put forward. The main peculiarity of requirements to a set of documents is provision of a certified copy of the contract between an applicant and a manufacturer of a medicinal product (in case of their difference).\u00a0\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The dossier is submitted in paper form, the possibility of filing the dossier in electronic form is not available.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Part of the documentation must be submitted with translation into Russian or Belarusian. Part of the administrative documentation must be submitted according to the requirements for international legalization of documents.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The stages of the registration procedure may be presented as follows:<\/span><\/p>\n<ol style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Preparation of the documents and payment for the initial expert evaluation.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Submission of the documents and implementation of the initial expert evaluation.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Obtaining the conclusion on the initial expert evaluation, obtaining the invoice and payment for the specialized expert evaluation.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Implementation of the specialized expert evaluation of the registration materials for the medicinal product, providing responses to expert observations if necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Implementation of laboratory control of samples according to a draft of the regulatory document for compliance with the requirements stated in the specifications; providing responses to expert observations if necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Inspection of the manufacturing site if necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Clinical trials in some cases if necessary.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Obtaining the conclusion on the specialized expert evaluation and adoption of the decision on recommending the medicinal product for registration at a meeting of the Academic Council of the Unitary Enterprise \u201cCenter for Expert Evaluation and Testing in Health Care\u201d.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Completion and issue of the original Registration Certificate.<\/span><\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The period of expert activities for state registration of the medicinal product is 6 months.\u00a0 A crucial point is that absolutely all activities must be completed within 6 months, including the expert evaluation of the documentation and the responses to observations, laboratory analysis of samples, inspection of the manufacturing site.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Inspection of manufacturing site\u00a0<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The procedure for inspection of manufacturing site is approved by Resolution No. 72 \u201cOn approval of instruction on cases and procedure for inspection of industrial production of medicinal products\u201d dated May 14, 2015.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Inspection is required during the first state registration of the site.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Inspection is carried out by a group of state experts. The Applicant of registration pays for the cost of the inspection activities, as well as transport and accommodation expenses.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The results of the inspection are valid for 5 years.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Language and labeling<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The package labeling, instructions for use and (or) package leaflet are submitted and approved in Russian or Belarusian. According to Resolution of the Ministry of Health of the Republic of Belarus dated May 5, 2009 No. 52 \u201cOn the requirements to the documents submitted for state registration\u2026\u201d (with amendments dd 05.11.2019), MAH has the choice of the language.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Registration certificate includes approved text of the instruction for use (or package leaflet) and color package artworks (mock-ups).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b>The Registration Certificate<\/b><span style=\"font-weight: 400;\"> is issued for a period of 5 years after the first registration, and indefinitely after renewal of registration. The medicinal product that has been placed on the market during the validity of the Registration Certificate validity is allowed to sale until the expiration date.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>The Registration Certificate consists of:<\/b><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The Registration Certificate itself with the Annex that indicates the declared price of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Permissions for use of the Normative document (ND). Whereas the Normative document itself (that includes the composition of the product, the specification for release and expiration date, quality control methods, etc.) is not amended to the package of the approved registration documents.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Instructions for medical use and\/or package leaflet.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Color primary and secondary package artworks (mock-ups).\u00a0<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Variations<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">According to the national legislation, the Application for variations should be submitted within three months from the date of approval by the competent authority of the manufacturing country (if this variation requires approval or notification procedure).\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Variations to the registration dossier should be applied in the following cases:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the name of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Reorganization or changes in the name of the manufacturer;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the manufacturer (country of the manufacturer) of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Addition of a new indication for medical use and (or) new method of administration (application) to the instructions for medical use of the medicinal product and (or) package leaflet;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Removal of an indication for medical use and (or) method of administration (application) previously approved from the instructions for medical use and (or) package leaflet;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Amendments to sections of the instructions for medical use of the medicinal product and (or) package leaflet, including the pharmacological and clinical sections;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the medicinal product composition as addition, removal or substitution of a pharmaceutical substance, excipient, colorant, flavor, stabilizer, preservative, tablet or capsule coating components;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the tests (quality parameters) indicated in the pharmacopoeial article or manufacturer&#8217;s regulatory document containing parameters and methods of quality control of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the shelf life of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in its storage conditions;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the quality control methods of the medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the material or type of its primary packaging;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the medicinal product manufacturing process;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the medicinal product package labeling;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Changes in the number of doses in the package when filling it.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Renewal of registration<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Application for renewal should be submitted not later than 3 months before expiry of the registration certificate. The renewal procedure is similar to the new registration.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">In-renewal quality control of the samples can be required in case of changes in the Specification and\/or control methods of the finished product. Inspection of the manufacturing site can be required.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The period of expert evaluation should not exceed 6 months.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Registration certificate without expiry will be issued based on the positive decision of the expert evaluation of renewal procedure.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Cratia provides professional services of state registration (renewals, variations) of medicinal products in Belarus. We have an excellent knowledge of national legislation, necessary experience and resources.\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">To start cooperation or get advice, please contact us by phone: +38 068 064-78-31, +38 044 223-61-67, by e-mail: <a href=\"mailto:info@cratia.ua\">info@cratia.ua<\/a>, or visit <a href=\"\/en\/contacts\/\">our office<\/a>.\u00a0<\/span><\/p>","protected":false},"featured_media":0,"parent":142,"menu_order":1,"template":"","class_list":["post-354","countries","type-countries","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries"}],"about":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/types\/countries"}],"up":[{"embeddable":true,"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/142"}],"wp:attachment":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/media?parent=354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}